Cori Clinical Bags $4M to Fix Medicine’s Billion-Dollar Protocol Trap
With an oversubscribed $4M seed round, Cori Clinical wants to simulate clinical trial protocols before costly amendments derail drug pipelines. Here is how.
Funding, founders, and the companies trying to build the next big thing.
With an oversubscribed $4M seed round, Cori Clinical wants to simulate clinical trial protocols before costly amendments derail drug pipelines. Here is how.
Nscale secures $3.36B in pre-IPO equity and debt to expand its gigawatt-scale AI infrastructure, proving that raw grid capacity is now tech's most valued asset.
Despite trillion-dollar AI valuations, female founders captured barely 2% of VC capital in 2026. The technical revolution forgot to fix its oldest culture problem.
Cornelis Networks has secured $205M to scale its open-standard fabrics, taking direct aim at Nvidia's high-margin InfiniBand monopoly in hyperscale AI clusters.
Inference startup d-Matrix will integrate Nvidia's NVLink interconnect into its AI server architecture, proving that in 2026, memory fabrics beat raw silicon.
With private venture capital plunging to decade lows, Singapore is injecting S$220M into high-risk fintech. Here is how state capital aims to reshape the sector.
Satellite intelligence startup Space-Eyes is going public in a $638 million SPAC deal. Here is what the political backing and defense tech pivot reveal.
Quantum computing faces a critical interconnect bottleneck. ZuriQ's $25.5M funding aims to solve physical qubit routing through a novel 2D planar array.
Airbus is anchoring a massive €500M defense tech venture fund, signaling Europe's shift toward sovereign militaries. Its first deal highlights AI warfare.
London-based robotics firm Humanoid raised $152 million in Series A funding at a $1.35 billion valuation. European physical AI is mounting a serious challenge.
Leaked emails and whistleblower documents reveal how a prominent diabetes startup silenced its chief medical officer to push unvalidated AI onto vulnerable patients.
Syntetica's $30M Series A highlights a major shift in materials science. Can its low-energy depolymerization tech finally make synthetic textiles fully circular?